Los puntos clave no están disponibles para este artículo en este momento.
!Figure1 Here, we describe a 52-year-old woman with a history of primary plasma cell leukemia (PCL) who achieved complete remission after the tandem of autologous and nonmyeloablative allogeneic stem cell transplantation (SCT). Nine months after the allogeneic SCT, she presented with
Donk et al. (Thu,) studied this question.